CSF neuroinflammatory biomarkers are associated with amyloid-β42/40, tau pathology, and cognitive impairment across the Alzheimer's disease spectrum.
Immunologic research · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAlzheimer DiseaseAmyloid beta-PeptidesBiomarkersFemaleMaleCognitive Dysfunctiontau ProteinsAgedPeptide FragmentsGlial Fibrillary Acidic ProteinAged, 80 and overReceptors, ImmunologicADAM17 ProteinMembrane GlycoproteinsNeuroinflammatory DiseasesReceptors, Tumor Necrosis Factor, Type IIAlzheimer’s diseaseCSF biomarkersCognitive impairmentNeuroinflammationNeuroinflammatory biomarkers
Come citare questo studio
Mubarak Alruwaili, Areej Ahmed Turkistani, Sireen Abdul Rahim Shilbayeh, Dahlia Soleman A Mirdad, Marwa Fareed Almulhim, Saud Alnaaim, Muhannad Almubarak, Alzheimer’s Disease Neuroimaging Initiative. (2026). CSF neuroinflammatory biomarkers are associated with amyloid-β42/40, tau pathology, and cognitive impairment across the Alzheimer's disease spectrum.. Immunologic research. DOI: 10.1007/s12026-026-09848-1
Consulta la pubblicazione originale ↗